1 / 1
Semaglutide mimics the natural hormone GLP-1, which is produced in the gut and plays a key role in regulating appetite and food intake. By activating GLP-1 receptors in the brain, semaglutide helps reduce hunger, thereby reducing calorie intake.
Semaglutide slows the rate at which food leaves the stomach and enters the small intestine, a process called delayed gastric emptying. This delayed gastric emptying leads to a prolonged feeling of fullness, which further reduces food intake.
Semaglutide enhances insulin secretion in a glucose-dependent manner, meaning it increases insulin release only when blood sugar levels are elevated. This helps improve blood sugar levels and reduces the risk of hypoglycemia.
Glucagon is a hormone produced by the pancreas that plays a key role in regulating blood sugar levels by stimulating the liver to release glucose into the blood. By inhibiting the release of glucagon, semaglutide helps lower blood sugar levels in people with diabetes. By reducing glucagon levels, semaglutide further helps maintain healthy blood sugar levels, which is particularly beneficial for people with type 2 diabetes.
Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to weight loss and improved body composition. It may also have a positive effect on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.
| Name | Semaglutide Injection Powder |
| Purity | 99% |
| Appearance | White Lyophilized Powder |
| Specification | 10mg, 15mg, 20mg, 30mg |
| Strength | 0.25 mg or 0.5 mg dose pen, 1 mg dose pen, 2mg dose pen. |
| Administration | Subcutaneous Injection |
| Benefits | weight loss |
Semaglutide mimics GLP-1, a natural gut hormone, and activates GLP-1 receptors in the brain to reduce feelings of hunger and lower overall calorie intake.
It slows down the rate at which food moves from the stomach into the small intestine, resulting in a prolonged feeling of fullness after eating.
Semaglutide enhances insulin secretion in a glucose-dependent manner, meaning it only triggers insulin release when blood sugar levels are elevated, thereby reducing the risk of hypoglycemia.
By suppressing the release of glucagon from the pancreas, Semaglutide prevents the liver from releasing excessive glucose into the bloodstream, helping maintain healthy blood sugar levels.
Semaglutide Injection Powder is prepared and administered via subcutaneous injection.
It increases energy expenditure, promotes fat burning, improves lipid metabolism, and significantly assists with weight loss and body composition improvement.
